Company: NKLR
Filing Date: 2025-05-14
Form Type: S-4
Source: 0001213900-25-043376
Chunk: 294

Company: Terra Innovatum Global N.V.
Filing Date: 2025-05-14
Form: S-4
Chunk 294
---
 International Atomic Energy Agency (“ IAEA”) are expected to support our efforts to obtain regulatory approvals abroad and provide additional confidence in our technology. We also anticipate benefiting from the NRC’s regulatory assistance programs, which facilitate collaboration and information sharing with other national regulators. Beyond nuclear safety, our activities are also subject to other regulatory controls, including export control laws, nuclear material safeguards, non -proliferationobligations, and liability insurance regimes such as the Price -AndersenAct and international conventions. Compliance with these additional requirements may further impact our operations, costs, and risk profile. 145 Patents and Proprietary Rights We strategically protect our intellectual property through a combination of patents, trademarks, trade secrets, confidentiality agreements, and licensing arrangements both domestically and internationally, with plans to strengthen this protection framework as our technology portfolio expands. Our pending and filed patent applications specifically address our advanced reactor designs, passive safety systems, digital twin technology, and specialized nuclear instrumentation and control systems critical to our micro modular reactor technologies. We also engage with international and local regulatory bodies and existing frameworks to safeguard our innovations across various jurisdictions. However, certain countries where our reactor components may be manufactured or where our reactor systems may be deployed may offer less robust protection for nuclear intellectual property compared to the United States or European Union regulatory environments. Our intellectual property strategy employs a systematic assessment framework considering: —Critical component manufacturing locations and supply chain considerations; —Strategic nuclear technology development pathways across different regulatory regimes; —Nuclear -specificintellectual property enforcement mechanisms in target deployment jurisdictions; and —Commercial significance relative to established and emerging competitors in specific nuclear markets and regions. We plan to establish licensing agreements for certain specialized nuclear technologies from third -partydevelopers and anticipate continued expansion of such arrangements as our reactor deployment roadmap advances. Manufacturing and supply chain We implement a fabless and contract manufacturing strategy, and expect to contract with key suppliers for all phases of the manufacturing process. We leverage the expertise of industry -leadingsuppliers that comply with nuclear quality assurance standards — including 10 CFR 50 Appendix B — in areas including fabrication, assembly, quality control, reliability testing, and certification. This approach allows Terra Innovatum to avoid the significant costs and risks associated with owning and operating manufacturing facilities while enabling scalability and rapid response to markets changing conditions. While we plan to directly procure certain critical raw materials used in our products, such as moderators, fuel, and specialized components, our suppliers are expected to manage procurement for most other components. This enables us to focus our resources on product design, licensing,